GENEURO SA (EPA:GNRO) | WebDisclosure

PRESS RELEASE

published on 05/29/2024 at 19:27, 6 months 23 days ago

Inside Information / Other news releases
GeNeuro announces availability of documents for the annual shareholders’ meeting on June 12, 2024 in Geneva, Switzerland. Documents accessible online and at company headquarters

Shareholders' Meeting Annual Meeting GeNeuro Geneva Documents Availability
PRESS RELEASE

published on 05/29/2024 at 19:27, 6 months 23 days ago

Informations privilégiées / Autres communiqués
GeNeuro annonce les modalités de mise à disposition des informations pour son assemblée générale des actionnaires du 12 juin 2024. Consultation en ligne ou au siège social à Genève

Actionnaires Assemblée Générale Modalités GeNeuro Genève
BRIEF

published on 04/30/2024 at 19:59, 7 months 21 days ago

GeNeuro présente ses résultats annuels 2023 et progresse dans ses programmes de recherche

Résultats Financiers Santé Recherche Médicale GeNeuro SA COVID Long
BRIEF

published on 04/30/2024 at 19:59, 7 months 21 days ago

GeNeuro presents its 2023 annual results and progresses in its research programs

Financial Results Long Covid Medical Research Health GeNeuro SA
PRESS RELEASE

published on 04/30/2024 at 19:54, 7 months 21 days ago

Inside Information / News release on accounts, results
GeNeuro reports 2023 full-year results and provides corporate update including completion of Phase 2 trial for temelimab against post-COVID neuropsychiatric syndromes. Financial visibility extended to Q3 2024

Full-year Results Phase 2 Trial GeNeuro Temelimab Post-COVID
PRESS RELEASE

published on 04/30/2024 at 19:54, 7 months 21 days ago

Informations privilégiées / Communiqué sur comptes, résultats
GeNeuro annonce ses résultats annuels 2023 et fait le point sur ses développements. Essai clinique de phase 2 avec temelimab dans les syndromes neuropsychiatriques Post-COVID. Position de trésorerie de 2,8 millions d'euros au 31 décembre 2023

Résultats Annuels GeNeuro Temelimab Syndromes Neuropsychiatriques Post-COVID

Published on 12/21/2024 at 01:30, 1 day 5 hours ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 5 hours ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 6 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 1 day 6 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 1 day 7 hours ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 1 day 5 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 1 day 5 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day 11 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 11 hours ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 18 hours 16 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 18 hours 16 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 12 hours ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News